Kornitzer Capital Management Inc. KS Acquires Shares of 50,000 Guardian Pharmacy Services, Inc. $GRDN

Kornitzer Capital Management Inc. KS bought a new position in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 50,000 shares of the company’s stock, valued at approximately $1,066,000. Kornitzer Capital Management Inc. KS owned 0.08% of Guardian Pharmacy Services at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Stephens Inc. AR bought a new position in Guardian Pharmacy Services during the second quarter worth $776,000. Allspring Global Investments Holdings LLC boosted its holdings in shares of Guardian Pharmacy Services by 0.5% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 285,885 shares of the company’s stock worth $6,092,000 after buying an additional 1,338 shares during the period. KLP Kapitalforvaltning AS acquired a new position in Guardian Pharmacy Services in the 2nd quarter valued at about $75,000. Woodline Partners LP grew its stake in Guardian Pharmacy Services by 1.5% in the 1st quarter. Woodline Partners LP now owns 421,203 shares of the company’s stock valued at $8,955,000 after buying an additional 6,083 shares during the last quarter. Finally, Dynamic Technology Lab Private Ltd bought a new position in Guardian Pharmacy Services in the 1st quarter valued at about $233,000.

Guardian Pharmacy Services Price Performance

Guardian Pharmacy Services stock opened at $28.47 on Monday. The firm has a market cap of $1.80 billion and a PE ratio of -18.73. The stock’s fifty day moving average price is $26.20 and its two-hundred day moving average price is $23.49. Guardian Pharmacy Services, Inc. has a one year low of $16.91 and a one year high of $30.39.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on the company. Weiss Ratings restated a “sell (d+)” rating on shares of Guardian Pharmacy Services in a report on Saturday. Oppenheimer began coverage on Guardian Pharmacy Services in a report on Friday, October 10th. They set an “outperform” rating and a $30.00 price target for the company. Truist Financial upped their price objective on Guardian Pharmacy Services from $28.00 to $30.00 and gave the company a “buy” rating in a report on Friday, September 26th. Finally, Wall Street Zen downgraded Guardian Pharmacy Services from a “strong-buy” rating to a “buy” rating in a report on Friday, October 3rd. Three investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat, Guardian Pharmacy Services presently has a consensus rating of “Moderate Buy” and an average target price of $29.33.

Guardian Pharmacy Services Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.